Mycobacterium tuberculosis | Appendix B: Panel Roster and Financial Disclosures | Adult and Adolescent Opportunistic Infection | ClinicalInfo

Guidelines for the Prevention and Treatment of Opportunistic Infections in Adults and Adolescents with HIV

The information in the brief version is excerpted directly from the full-text guidelines. The brief version is a compilation of the tables and boxed recommendations.

Updated

Jan. 01, 2020

Reviewed

Aug. 01, 2019

Appendix B: Panel Roster and Financial Disclosures

Mycobacterium tuberculosis

*Mycobacterium tuberculosis* Infection and Disease
Member		Financial Disclosure
Member		Company	Relationship
Brust, James*	Albert Einstein College of Medicine	None	N/A
Dooley, Kelly	Johns Hopkins University	None	N/A
Goswami, Neela	Centers for Disease Control and Prevention	None	N/A
Heysell, Scott	University of Virginia	Bill and Melinda Gates Foundation	Research Support
		Elton John AIDS Foundation	Research Support
		National Institutes of Health	Research Support
		UpToDate	Royalties
Maartens, Gary	University of Cape Town, South Africa	ViiV	Advisory Board
Meintjes, Graeme	University of Cape Town, South Africa	Bill and Melinda Gates Foundation	Research Support
Shah, Sarita	Centers for Disease Control and Prevention	None	N/A
Sterling, Timothy	Vanderbilt University Medical Center	Centers for Disease Control and Prevention	Research Support
		CRDF Global	Research Support
		National Institutes of Health	Research Support
		UpToDate	Royalties
Group lead Note:* Members were asked to disclose all relationships from 12 months prior to the updated date. The period of reporting was from August 1, 2018, through August 1, 2019.

Download Guidelines

Section OnlyPDF (337.79 KB)
Full GuidelinePDF (3.78 MB)
Tables OnlyPDF (481.21 KB)